Advanced search
Publication Cover
Vascular Health and Risk Management Volume 14, 2018 - Issue
Submit an article Journal homepage
63
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Antihypertensive effect of the mineralocorticoid receptor antagonist eplerenone: a pooled analysis of patient-level data from comparative trials using regulatory-approved doses

Mireille Fernet1 Department of Medical Affairs, Pfizer Canada Inc., Kirkland, QC, Canada
,
Bruce Beckerman2 Department of Clinical Affairs, Pfizer Inc., New York, NY, USA
,
Paula Abreu2 Department of Clinical Affairs, Pfizer Inc., New York, NY, USA
,
Katharina Lins3 Department of Medical Affairs, Pfizer Ltd., Tadworth, UK
,
John Vincent2 Department of Clinical Affairs, Pfizer Inc., New York, NY, USA
&
Ellen Burgess4 Department of Medicine, Faculty of Medicine, University of Calgary, Calgary, AB, Canada, [email protected]Correspondence[email protected]
Pages 233-246 | Published online: 20 Sep 2018

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.